济民健康
(603222)
| 流通市值：42.37亿 | | | 总市值：42.37亿 |
| 流通股本：5.25亿 | | | 总股本：5.25亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 337,635,982.5 | 163,097,985.21 | 685,962,950.12 | 544,718,299.64 |
| 营业总成本 | 374,357,144.04 | 185,180,092.87 | 808,988,867.45 | 592,923,784.23 |
| 其他经营收益 | | | | |
| 营业利润 | -45,958,773.68 | -22,534,596.99 | -207,028,771.62 | -89,830,454.23 |
| 利润总额 | -47,928,915 | -22,692,766.17 | -233,948,661.97 | -90,708,066.75 |
| 净利润 | -50,722,175.63 | -24,248,274.2 | -246,819,798.54 | -75,369,256.91 |
| 每股收益 | | | | |
| 其他综合收益 | -3,703,372.05 | -2,493,891.59 | 6,170,174.69 | 7,332,986.44 |
| 综合收益总额 | -54,425,547.68 | -26,742,165.79 | -240,649,623.85 | -68,036,270.47 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 672,934,943.09 | 558,702,104.65 | 585,291,429 | 683,078,328.35 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,537,360,176.78 | 1,709,726,675.59 | 1,724,347,344.02 | 1,812,881,695.62 |
| 资产总计 | 2,210,295,119.87 | 2,268,428,780.24 | 2,309,638,773.02 | 2,495,960,023.97 |
| 流动负债: | | | | |
| 流动负债合计 | 716,798,429.79 | 712,448,701.59 | 634,416,890.98 | 665,932,667.63 |
| 非流动负债: | | | | |
| 非流动负债合计 | 320,473,804.33 | 355,273,811.01 | 369,669,502.97 | 341,988,203.46 |
| 负债合计 | 1,037,272,234.12 | 1,067,722,512.6 | 1,004,086,393.95 | 1,007,920,871.09 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,088,195,306.13 | 1,112,906,437.46 | 1,219,425,658.71 | 1,398,916,578.17 |
| 股东权益合计 | 1,173,022,885.75 | 1,200,706,267.64 | 1,305,552,379.07 | 1,488,039,152.88 |
| 负债和股东权益合计 | 2,210,295,119.87 | 2,268,428,780.24 | 2,309,638,773.02 | 2,495,960,023.97 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 394,348,952.52 | 193,604,656.97 | 788,033,869.46 | 604,789,419.39 |
| 经营活动现金流出小计 | 381,779,874.14 | 168,023,578.9 | 798,385,432.94 | 637,042,014.27 |
| 经营活动产生的现金流量净额 | 12,569,078.38 | 25,581,078.07 | -10,351,563.48 | -32,252,594.88 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 161,015,896 | 10,902 | 150,413,228.11 | 150,347,400.2 |
| 投资活动现金流出小计 | 44,676,421.02 | 31,850,165.08 | 358,872,146.21 | 341,658,287.45 |
| 投资活动产生的现金流量净额 | 116,339,474.98 | -31,839,263.08 | -208,458,918.1 | -191,310,887.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 337,260,600 | 166,260,600 | 634,760,000 | 397,880,000 |
| 筹资活动现金流出小计 | 350,153,855.43 | 165,887,875.71 | 501,154,860.72 | 219,953,526.23 |
| 筹资活动产生的现金流量净额 | -12,893,255.43 | 372,724.29 | 133,605,139.28 | 177,926,473.77 |
| 汇率变动对现金及现金等价物的影响 | -879,589.43 | -95,795.38 | -1,395,418.1 | 740,647.19 |
| 现金及现金等价物净增加额 | 115,135,708.5 | -5,981,256.1 | -86,600,760.4 | -44,896,361.17 |
| 期末现金及现金等价物余额 | 326,931,446.6 | 205,814,482 | 211,795,738.1 | 253,500,137.33 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 115,135,708.5 | - | -86,600,760.4 | - |